{"entity":{"type":"insider","cik":"0001573163","url":"/insider/0001573163","json_url":"/insider/0001573163.json","name":"Ashe Andrew D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2013-08-15","last":"2025-04-03","span_basis":"filed_date"},"name_variants":[{"name":"Ashe Andrew D.","source":"filing","n_filings":9,"first_seen":"2013-08-15","last_seen":"2025-04-03"}],"transactions":[{"id":4131785,"accession":"0000950170-25-050561","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-050561","line_url":"/filing/0000950170-25-050561#line-2","is_derivative":false,"issuer_cik":"0001573163","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001573163","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2681.0,"shares_display":"2,681","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":11126.15,"total_display":"11,126.15","total_whole":"11,126","shares_owned_after":348828.0,"shares_owned_after_display":"348,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-02","filed_date":"2025-04-03","scope":"insider"},{"id":2141695,"accession":"0000950170-24-060613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-060613","line_url":"/filing/0000950170-24-060613#line-1","is_derivative":false,"issuer_cik":"0001573163","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001573163","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76000.0,"shares_display":"76,000","price_per_share":6.26,"price_display":"6.26","price_state":"stated","total_value":475760.0,"total_display":"475,760.00","total_whole":"475,760","shares_owned_after":342509.0,"shares_owned_after_display":"342,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-15","scope":"insider"},{"id":4452523,"accession":"0000899243-21-046888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-046888","line_url":"/filing/0000899243-21-046888#line-1","is_derivative":false,"issuer_cik":"0001573163","issuer_name":"Verve Therapeutics, Inc.","issuer_ticker":"VERV","issuer_name_source":null,"issuer_url":"/issuer/0001573163","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":32.1049,"price_display":"32.10","price_state":"stated","total_value":128419.6,"total_display":"128,419.60","total_whole":"128,420","shares_owned_after":170722.0,"shares_owned_after_display":"170,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-02","filed_date":"2021-12-06","scope":"insider"},{"id":8913359,"accession":"0000908662-15-000276","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000908662-15-000276","line_url":"/filing/0000908662-15-000276#line-2","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & EVP)","role_mark":"O","role_mark_label":"Officer (General Counsel & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62320.0,"shares_display":"62,320","price_per_share":24.2139,"price_display":"24.21","price_state":"stated","total_value":1509010.248,"total_display":"1,509,010.25","total_whole":"1,509,010","shares_owned_after":34127.0,"shares_owned_after_display":"34,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-05","scope":"insider"},{"id":8856220,"accession":"0000908662-15-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-15-000115","line_url":"/filing/0000908662-15-000115#line-1","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & EVP)","role_mark":"O","role_mark_label":"Officer (General Counsel & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":37200.0,"total_display":"37,200.00","total_whole":"37,200","shares_owned_after":34127.0,"shares_owned_after_display":"34,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-06","scope":"insider"},{"id":8316833,"accession":"0000908662-15-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-15-000097","line_url":"/filing/0000908662-15-000097#line-1","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & EVP)","role_mark":"O","role_mark_label":"Officer (General Counsel & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":15.34,"price_display":"15.34","price_state":"stated","total_value":23010.0,"total_display":"23,010.00","total_whole":"23,010","shares_owned_after":36527.0,"shares_owned_after_display":"36,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-26","filed_date":"2015-02-26","scope":"insider"},{"id":6173407,"accession":"0000908662-14-000105","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000908662-14-000105","line_url":"/filing/0000908662-14-000105#line-3","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & EVP)","role_mark":"O","role_mark_label":"Officer (General Counsel & EVP)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & EVP","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":36277.0,"shares_owned_after_display":"36,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-03","scope":"insider"},{"id":6891376,"accession":"0000908662-14-000089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000908662-14-000089","line_url":"/filing/0000908662-14-000089#line-1","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & Sr. VP, Adm)","role_mark":"O","role_mark_label":"Officer (General Counsel & Sr. VP, Adm)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Sr. VP, Adm.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2723.0,"shares_display":"2,723","price_per_share":10.1,"price_display":"10.10","price_state":"stated","total_value":27502.3,"total_display":"27,502.30","total_whole":"27,502","shares_owned_after":12277.0,"shares_owned_after_display":"12,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-26","scope":"insider"},{"id":4431280,"accession":"0000908662-13-000264","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000908662-13-000264","line_url":"/filing/0000908662-13-000264#line-5","is_derivative":false,"issuer_cik":"0000907562","issuer_name":"DYAX CORP","issuer_ticker":"DYAX","issuer_name_source":null,"issuer_url":"/issuer/0000907562","owner_cik":"0001573163","owner_name":"Ashe Andrew D.","owner_display_name":"Ashe Andrew D.","owner_url":"/insider/0001573163","role":"Officer (General Counsel & Sr. VP, Adm)","role_mark":"O","role_mark_label":"Officer (General Counsel & Sr. VP, Adm)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel & Sr. VP, Adm.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32500.0,"shares_display":"32,500","price_per_share":4.3,"price_display":"4.30","price_state":"stated","total_value":139750.0,"total_display":"139,750.00","total_whole":"139,750","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-13","filed_date":"2013-08-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840574","name":"Verve Therapeutics, Inc.","url":"/issuer/0001840574","role":"Officer","n_filings":3,"first_seen":"2021-12-06","last_seen":"2025-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000907562","name":"DYAX CORP","url":"/issuer/0000907562","role":"Officer (General Counsel & EVP)","n_filings":6,"first_seen":"2013-08-15","last_seen":"2015-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001573163","retrieved_at":"2026-08-23T11:18:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}